Report an error

Spotted something inaccurate in “Adjuvant Nivolumab Shows No Survival Benefit in Resected Lung Cancer Trial”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.